SCHEMBL4611122

SCHEMBL4611122

CC(C)(N)COS(=O)(=O)O

nearest known ligand 0.31

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CA2 P00918 2/20 0.31
CA1 P00915 1/20 0.31
CA9 Q16790 1/20 0.31
GRM4 Q14833 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acrylic Acid Methyl Ester SCHEMBL4065761 0.82 ALDH1A1 (0.33)
SCHEMBL13997141 0.79 CA2 (0.33) CA2CA1CA9
SCHEMBL17469828 0.79 CA2 (0.33) CA2
SCHEMBL9177881 0.79 CYP2C19 (0.36) CA2
SCHEMBL1889753 0.79 CA2 (0.33) CA2
SCHEMBL11652653 0.78 CA1 (0.33) CA2CA1CA9
SCHEMBL12999204 0.77 USP2 (0.42) CA2CA1CA9
SCHEMBL12533296 0.77 CA2 (0.32) CA2
Hydrochloric Acid SCHEMBL29798815 0.77 CYP2C19 (0.35) CA2
Ammonia Solution, Strong SCHEMBL28099420 0.77 CYP2C19 (0.35) CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11261271-B2 Thermosensitive phosphazene-based polymer comprising sulfate moiety, and preparation method and use thereof KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2022-03-01 US disclosed
US-20200048377-A1 Thermosensitive phosphazene-based polymer comrising sulfonated moiety, and preparation method and use thereof NEXGEL BIOTECH CO., LTD (KR) 2020-02-13 US disclosed
US-8236810-B2 Substituted 8-aminoalkylthioxanthines, and their use as inhibitors of dipeptidyl peptidase IV SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2012-08-07 US disclosed
EP-1981841-A1 PREPARATION OF THIOALKYLAMINES USING CHLOROSULFONIC ACID Bayer CropScience AG (DE) 2008-10-22 EP disclosed
US-20070265284-A1 SUBSTITUTED 8-AMINOALKYLTHIOXANTHINES, AND THEIR USE AS INHIBITORS OF DIPEPTIDYL PEPTIDASE IV SANOFI-AVENTIS DEUTSCHLAND GMBH (DE) 2007-11-15 US disclosed
WO-2007022901-A1 PREPARATION OF THIOALKYLAMINES USING CHLOROSULFONIC ACID BAYER CROPSCIENCE AG (DE) 2007-03-01 WO disclosed
US-4196260-A AMINOPHOSPHORINANE, AMINO RESIN CIBA-GEIGY CORPORATION (US) 1980-04-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265284-A1 SUBSTITUTED 8-AMINOALKYLTHIOXANTHINES, AND THEIR USE AS INHIBITORS OF DIPEPTIDYL PEPTIDASE IV DPP4, DPP8, DPP7 CA2 1390/4885CA1 4373/4885CA9 1488/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.